Articles liés à The Role of Subsidiaries in Strategic Technology Alliances:...

The Role of Subsidiaries in Strategic Technology Alliances: The Pharmaceutical Industry Case - Couverture souple

Iaia, Alice

 
9783844396652: The Role of Subsidiaries in Strategic Technology Alliances: The Pharmaceutical Industry Case
Couverture souple
ISBN 10 : 3844396659 ISBN 13 : 9783844396652
Editeur : LAP LAMBERT Academic Publishing, 2011

Synopsis

This project starts from two emerging trends in multinational enterprise management which have received a lot of attention in literature: the establishment of global R&D networks, and the related increased subsidiaries autonomy, and the explosion in alliances from the 1980s on. This work puts together these two knowledge fields in order to explore the degree of subsidiaries autonomy in strategic technology alliances. Three case studies, namely Roche, GlaxoSmithKline and Novartis, have been proposed: in all of them, R&D structure includes the presence of foreign subsidiaries in charge of R&D activities with a good level of autonomy. This leads to the fact that they are involved in the implementation of alliances, executing the activities agreed. However, as far as the possibility of developing collaborations on their own is concerned, evidence is mixed. This work is successful in providing some valuable insight to people interested in the role of subsidiaries in developing and managing strategic technology alliances.

Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.

Présentation de l'éditeur

This project starts from two emerging trends in multinational enterprise management which have received a lot of attention in literature: the establishment of global R&D networks, and the related increased subsidiaries autonomy, and the explosion in alliances from the 1980s on. This work puts together these two knowledge fields in order to explore the degree of subsidiaries autonomy in strategic technology alliances. Three case studies, namely Roche, GlaxoSmithKline and Novartis, have been proposed: in all of them, R&D structure includes the presence of foreign subsidiaries in charge of R&D activities with a good level of autonomy. This leads to the fact that they are involved in the implementation of alliances, executing the activities agreed. However, as far as the possibility of developing collaborations on their own is concerned, evidence is mixed. This work is successful in providing some valuable insight to people interested in the role of subsidiaries in developing and managing strategic technology alliances.

Biographie de l'auteur

Master of Science in International Management at Bocconi University, Italy. Working in Roland Berger Strategy Consultants

Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.

Éditeur
LAP LAMBERT Academic Publishing
Date d'édition
2011
Langue
anglais
ISBN 10 
3844396659
ISBN 13 
9783844396652
Reliure
Broché
Nombre de pages
84
Coordonnées du fabricant
non disponible
Personne responsable
KreGa Onlinehandel GmbH
4950000000000
info@krega-onlinehandel.de

Birkenweg 31
Brakel
33034
Allemagne